News
Zacks.com on MSN5m
MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer
Merck's ifinatamab deruxtecan wins FDA Breakthrough Therapy status for treating adults with extensive-stage small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback